Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $86.7461 (-3.28%) ($86.4003 - $90.2827) on Wed. Jan. 9, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.29% (three month average) | RSI | 61 | Latest Price | $86.7461(-3.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.3% a day on average for past five trading days. | Weekly Trend | ABBV advances 2.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(60%) VYM(50%) IVE(49%) SPLV(49%) IWD(48%) | Factors Impacting ABBV price | ABBV will decline at least -1.145% in a week (0% probabilities). DIA(-15%) TLT(-14%) VXX(-12%) UUP(-12%) VIXM(-11%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.145% (StdDev 2.29%) | Hourly BBV | 0 () | Intraday Trend | -3.4% | | | |
|
5 Day Moving Average | $87.79(-1.19%) | 10 Day Moving Average | $88.47(-1.95%) | 20 Day Moving Average | $86.64(0.12%) | To recent high | -6.9% | To recent low | 12.8% | Market Cap | $153.045b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |